| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |